Physician profile
Michael Palmer
NPI 1497136006
$9,651.50
in general payments reported to CMS, 2019-2025
36 companies · $2,089 in 2025
The $2,089 reported for 2025 was more than what 82% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $446 · 2020: $219 · 2021: $92.16 · 2022: $1,002 · 2023: $2,229 · 2024: $3,574 · 2025: $2,089.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,092 · Travel and Lodging: $1,801 · Grant: $1,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,091.87 |
| Travel and Lodging | $1,800.56 |
| Grant | $1,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $4,272.55 | 2022-2025 | Valiant Captivia, Endurant Iis, Penditure |
| Ctl Medical Corporation | $1,621.16 | 2024 | Spinal |
| W. L. Gore & Associates, INC. | $808.69 | 2020-2025 | Gore Tag Conformable Thoracic Endoprosthesis, Gore Viabahn Vbx Balloon Expandable Endo, Gore Tag Thoracic Branch Endoprosthesis |
| Silk Road Medical, INC. | $494.33 | 2019-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Bolton Medical INC | $492.92 | 2022-2025 | Treo Abdominal Stent-Graft System, Thoraflex Hybrid, Gelweave |
| Inari Medical, INC. | $396.78 | 2023-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Surmodics, INC. | $262.89 | 2023-2025 | Pounce Venous Thrombectomy System, Pounce Thrombectomy System, Pounce Thrombectomy |
| Boston Scientific Corporation | $189.07 | 2020-2025 | Enroute Transcarotid Neuroprotection System |
| Medtronic Vascular, INC. | $159.17 | 2019 | |
| Abiomed | $152.36 | 2023-2025 | Impella |
| Acell, INC. | $124.16 | 2019 | |
| Endologix LLC | $72.80 | 2024 | Torus Stent Graft System, Endocross Device |
| Janssen Pharmaceuticals, INC | $60.42 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $43.71 | 2023-2024 | Jardiance |
| Karl Storz Endoscopy-America | $39.90 | 2023 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $37.51 | 2022-2023 | |
| Corcym INC | $33.73 | 2023 | Perceval |
| Atricure, INC. | $31.16 | 2024 | |
| Chiesi USA, INC. | $30.22 | 2022-2023 | Cleviprex, Kengreal |
| Depuy Synthes Sales INC. | $29.30 | 2025 | |
| Edwards Lifesciences Corporation | $26.86 | 2025 | Evoque |
| Astrazeneca Pharmaceuticals LP | $24.15 | 2023 | Andexxa |
| Actelion Pharmaceuticals US, INC. | $24.11 | 2022 | |
| Merck Sharp & Dohme LLC | $23.18 | 2024 | Verquvo |
| Kestra Medical Technology Services, INC. | $23.18 | 2023 | Assure Wcd |
| Ethicon US, LLC | $23.15 | 2019 | |
| Cvrx, INC. | $20.39 | 2025 | Barostim Neo System |
| Esperion Therapeutics, INC. | $19.29 | 2024 | Nexletol |
| Centerline Biomedical INC. | $17.56 | 2022 | |
| Tactile Systems Technology INC | $16.09 | 2024 | Entre Plus, Flexitouch Plus |
| Stryker Corporation | $15.13 | 2025 | Artix Mt |
| E.R. Squibb & Sons, L.L.C. | $14.68 | 2023 | |
| Amgen INC. | $14.53 | 2023 | Repatha |
| Lemaitre Vascular, INC. | $13.91 | 2023 | Hydro Lemaitre Valvulotome |
| Angiodynamics, INC. | $13.48 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $8.98 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Palmer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.